NYSEConsumer StaplesPackaged FoodsSnapshot 2026-07-23
Reading USNA? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a stable growth opportunity in the Consumer Staples sector. The current thesis state is intact, supported by recent earnings beats and a positive revenue trajectory.
The market currently reflects a justified valuation with low fragility. There is a slight expectations gap, indicating that the stock is priced in alignment with its fundamentals compared to peers.
Management is on track to meet revenue guidance, but there is mixed progress towards earnings per share and adjusted EBITDA targets. Near-term risks are low, but the company's smaller size introduces some volatility.
The thesis hinges on maintaining guidance in the next earnings call and external factors like inflation trends and performance of sector peers. A cut in guidance could lead to negative sentiment.
Overall, USNA's fundamentals are stable, but external factors will play a crucial role in its performance. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Reaffirming revenue guidance shows USANA is on track for growth. This could boost investor confidence.
Confirms:Management confirms revenue guidance of $925M to $1.0B during the Q2 earnings call.
Disproves:Management cuts revenue guidance to below $925M during the Q2 earnings call.
Why it matters: Meeting or exceeding revenue guidance shows USANA is on track for growth. This supports investor confidence.
Confirms:Q2 revenue reported at or above $231M, aligning with the guidance of $925M to $1.0B for FY 2026.
Disproves:Q2 revenue is under $231M. This shows challenges in reaching the annual growth goal.
Why it matters: Meeting or exceeding the revenue guidance would show USANA's growth strategy is working. It would also help restore investor confidence after a flat Q1.
Confirms:In Q2 2026, net sales were over $925 million.
Disproves:In Q2 2026, net sales were below $925 million.
Why it matters: Growth signals in the sector could impact USANA's performance. A positive trend would support USANA's growth story.
Confirms one read:Consumer staples revenue growth speeds up to above 3% year over year.
Confirms the other:Consumer staples revenue growth falls below 1% year over year.
Why it matters: If adjusted EBITDA matches guidance, it shows USANA is controlling costs well. This could make investors feel better.
Confirms:Q2 adjusted EBITDA reported at or above $101M.
Disproves:Q2 adjusted EBITDA is reported at below $101M.
Why it matters: If revenue growth picks up, it shows USANA is overcoming sector challenges. This could improve investor confidence.
Confirms:Revenue growth reported above 4% year over year in the next earnings report.
Disproves:Revenue growth remains below 4% year over year in the next earnings report.
Why it matters: The consumer price index data can impact consumer spending and USANA's sales. It helps gauge inflation's effect on the health products market.
Confirms one read:CPI data shows the inflation rate is below 2%. This indicates stable consumer spending.
Confirms the other:CPI data shows the inflation rate is above 4%. This suggests pressure on consumer spending.
Why it matters: If USANA meets or beats EPS guidance, it shows they are making more money. This could help the stock.
Confirms:Q2 diluted EPS reported at or above $1.11.
Disproves:Q2 diluted EPS reported below $1.11.
Why it matters: More subscribers would show that Hiya is doing well. This matters for USANA's growth.
Confirms:Hiya active monthly subscribers increase to 200,000 in Q2 2026.
Disproves:Hiya active monthly subscribers drop below 180,000 in Q2 2026.
Why it matters: More sales in Rise Wellness would prove USANA's product ideas and market growth are working.
Confirms:Rise Wellness net sales exceed $20 million in Q2 2026.
Disproves:Rise Wellness net sales fall below $10 million in Q2 2026.
